What does Kardium do?
Kardium is a Vancouver-based developer specializing in the globe pulsed field system, a cutting-edge treatment for atrial fibrillation that uses a catheter with a 122-electrode array and advanced software for rapid pulmonary vein isolation and high-definition mapping.
How much did they raise?
The funding round saw a $250M investment led by Janus Henderson Investors, Qatar Investment Authority, MMCAP, Piper Heartland Healthcare Capital, Eventide Asset Management, and Eckuity Capital, with participation from existing investors such as T. Rowe Price and Durable Capital Partners LP.
What are their plans for the money?
The company intends to use the funds to pursue regulatory approvals, expand its manufacturing facilities and production capacity, and establish a dedicated clinical support and commercial team ahead of the anticipated launch of the Globe System later this year.
What have they achieved so far?
Kardium has built an outstanding team in collaboration with top medical advisors, successfully developing the innovative Globe System that promises a transformative approach to treating atrial fibrillation.